Personal information

No personal information available

Activities

Collapse all

Works (14)

Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma

Cancers
2021-12 | Journal article | Author
DOI: 10.3390/cancers13246266
Contributors: Yasuyoshi Sato; Kenji Nakano; Xiaofei Wang; Naoki Fukuda; Tetsuya Urasaki; Akihiro Ohmoto; Naomi Hayashi; Mayu Yunokawa; Makiko Ono; Junichi Tomomatsu et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Clinical Indications for Treatment with Multi-Kinase Inhibitors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer

Cancers
2021-05 | Journal article | Author
DOI: 10.3390/cancers13092279
Contributors: Naoki Fukuda; Shunji Takahashi
Source: check_circle
Multidisciplinary Digital Publishing Institute

Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients

Cancer Reports
2020-12-09 | Journal article
DOI: 10.1002/cnr2.1322
Part of ISSN: 2573-8348
Part of ISSN: 2573-8348
Source: Self-asserted source
Naoki Fukuda

Screening for COVID-19 in Symptomatic Cancer Patients in a Cancer Hospital

Cancer Cell
2020-11 | Journal article
DOI: 10.1016/j.ccell.2020.09.017
Part of ISSN: 1535-6108
Source: Self-asserted source
Naoki Fukuda

Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel

European Archives of Oto-Rhino-Laryngology
2020-11-21 | Journal article
DOI: 10.1007/s00405-020-06481-y
Part of ISSN: 0937-4477
Part of ISSN: 1434-4726
Source: Self-asserted source
Naoki Fukuda

An extragonadal germ cell tumor with dermatomyositis: A case report and literature review.

Molecular and clinical oncology
2020-09-03 | Journal article
DOI: 10.3892/mco.2020.2130
PMID: 32953114
PMC: PMC7484733
Source: Self-asserted source
Naoki Fukuda

Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib.

In vivo (Athens, Greece)
2020-09-01 | Journal article
DOI: 10.21873/invivo.12113
PMID: 32871825
Source: Self-asserted source
Naoki Fukuda

Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial.

Cancer management and research
2020-06-03 | Journal article
DOI: 10.2147/cmar.s249393
PMID: 32581587
PMC: PMC7280058
Source: Self-asserted source
Naoki Fukuda

Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer.

BMC cancer
2020-04-21 | Journal article
DOI: 10.1186/s12885-020-06865-7
PMID: 32316940
PMC: PMC7175590
Source: Self-asserted source
Naoki Fukuda

Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib.

In vivo (Athens, Greece)
2020-03-01 | Journal article
DOI: 10.21873/invivo.11828
PMID: 32111774
PMC: PMC7157845
Source: Self-asserted source
Naoki Fukuda

Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study.

BMC cancer
2019-07-03 | Journal article
DOI: 10.1186/s12885-019-5720-3
PMID: 31269916
PMC: PMC6610828
Source: Self-asserted source
Naoki Fukuda

A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer.

Future oncology (London, England)
2019-01-14 | Journal article
DOI: 10.2217/fon-2018-0557
PMID: 30638399
Source: Self-asserted source
Naoki Fukuda

Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel.

Oncotarget
2018-03-08 | Journal article
DOI: 10.18632/oncotarget.24635
PMID: 29632638
PMC: PMC5880598
Source: Self-asserted source
Naoki Fukuda

Role of targeted therapy in metastatic colorectal cancer

World Journal of Gastrointestinal Oncology
2016 | Journal article
DOI: 10.4251/wjgo.v8.i9.642
ISSN: 1948-5204
Source: Self-asserted source
Naoki Fukuda

Peer review (2 reviews for 2 publications/grants)

Review activity for Clinical & translational oncology. (1)
Review activity for Endocrine. (1)
How many people are using ORCID?